Supports CAR T cell trials for brain tumor, solid tumor, and leukemia patients. Scientists and researchers at Seattle Children's Therapeutics are devoted to envisioning and testing next-generation cell and gene therapies for pediatric diseases so children have the medicines they deserve. The team has designed, manufactured, and launched a robust portfolio of CAR T-cell immunotherapy clinical trials for brain tumor, solid tumor and leukemia patients.
